UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Auto investing in Dividend Aristocrats ETF helps maintain discipline and harness compounding. Here's why this approach supports steady, long-term growth.
21,043 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
The SEC has postponed the draft innovation exemption for tokenized stocks, signaling a longer path to allowing tradin...
Drones and government funding chatter are reshaping investor sentiment. Ondas is at the center of the action, with ot...
As Signet gears up for 2026, investors should focus on earnings drivers, margin dynamics, and the evolving omnichanne...
Alphabet's plan to issue new stock could dilute existing holders. This deep dive explains what that means for investo...
A top cloud platform just posted a record-breaking quarter as Micron pulls back, prompting investors to shift toward ...
Retirees face a shifting rate landscape. This guide explains how a possible 2026 rate rise could affect income, withd...
A strategic expansion at Energy Transfer's Nederland NGL Export Terminal aims to boost export capacity and support a ...
With $850,000 saved at 59, a couple can expect about $2,600-$2,800 a month in early retirement from portfolios, befor...
July brought steadier ground for stocks as AI chip makers led a tech rally. This guide breaks down the drivers, what ...
Investors are turning to ASML to gauge the health of the global chip cycle. This article breaks down the factors like...
Investing in builders requires more than chasing growth. This deep dive unpacks why dream finders homes: promising st...